The latest announcement is out from Genor Biopharma Holdings Limited ( (HK:6998) ).
Genor Biopharma Holdings Limited, a company incorporated in the Cayman Islands, has announced a change in its principal place of business in Hong Kong. Effective January 10, 2025, the new address will be Room 1920, 19/F, Lee Garden One, 33 Hysan Avenue, Causeway Bay, Hong Kong. This relocation may reflect strategic operational adjustments or an expansion of their business activities in the region.
More about Genor Biopharma Holdings Limited
YTD Price Performance: 0.0%
Average Trading Volume: 20,382
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €119.5M
See more insights into 6998 stock on TipRanks’ Stock Analysis page.